Skip to main content

Table 1 Baseline Participant Characteristics

From: Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial

  All (N = 30) HIIT group (N = 15) CON Group (N = 15)
Age, years, mean (SD) 46.9 (9.8) 49.1 (7.9) 44.7 (11.2)
Menopausal status
 Premenopausal 11 (37) 5 (33) 6 (40)
 Postmenopausal 19 (63) 10 (67) 9 (60)
Body Weight, kg, mean (SD) 77.7 (18.3) 80.9 (17.7) 74.5 (18.8)
Height, cm, mean (SD) 158.4 (8.2) 156.5 (6.6) 160.3 (9.9)
BMI, kg/m2, mean (SD) 31.6 (7.7) 33.1 (7.6) 30.1 (7.7)
Race/ethnicity
 Non-Hispanic white 4 (13) 3 (20) 1 (6)
 Hispanic white 22 (73) 11 (74) 11 (74)
 African American 2 (7) 0 (0) 2 (14)
 Asian/Pacific Islander 2 (7) 1 (6) 1 (6)
Disease stage
 I 2 (7) 1 (6) 1 (6)
 II 9 (30) 5 (30) 4 (24)
 III 19 (63) 9 (64) 10 (70)
Chemotherapy
 Neoadjuvant 23 (77) 11 (73) 12 (80)
 Adjuvant 7 (23) 4 (27) 3 (20)
International physical activity questionnaire (MET min per week of moderate to vigorous intensity recreational activity), mean (SD) 462.5 (101.2) 480.9 (85.3) 441.9 (93.2)
  1. Note. Data are presented as No. (%) unless otherwise indicated. No significant baseline differences between groups were observed (p > 0.05) by independent sample t tests for continuous variables and Pearson X2 and Fisher’s exact tests for categorical variables
  2. Abbreviations: BMI body mass index, HIIT high intensity interval training, DEL delayed, MET metabolic equivalents, SD standard deviation